PlaqueTec recruits first ten patients in BIOPATTERN trial

PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), today announced that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.

Study sheds light on how COVID-19 infection may lead to late pregnancy complications

The Hong Kong University of Science and Technology (HKUST) and The Chinese University of Hong Kong (CUHK) today unveiled ground-breaking research that sheds light on

July 13, 2023

Serious Chocolate Recall; Boy Dies in Hyperbaric Chamber; Trans Care Cancellations

Note that some links may require registration or subscription. The FDA classified the recall of Cal Yee Farm’s chocolate and yogurt-covered products as Class I

February 4, 2025

Numinus to Host Q3 2023 Results Conference Call on July 17, 2023 | Psychedelic Invest

Numinus Wellness Inc. (TSX: NUMI / OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, will release its financial results

June 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.